Abstract
Background: When direct‐current (DC) cardioversion is used, sinus rhythm can be restored, at least temporarily, in 80–90% of patients with atrial fibrillation. However, there is a small but significant group of patients with chronic atrial fibrillation in whom DC cardioversion has failed to restore sinus rhythm. The value of antiarrhythmic drug pretreatment before DC cardioversion is still controversial.
Hypothesis: The aim of our study was to assess (1) the effecti veness of repeat DC cardioversion in patients with chronic atrial fibrillation after pretreatment with amiodarone, and (2) the efficacy of amiodarone in maintaining sinus rhythm after repeat cardioversion.
Methods: Forty‐nine patients with chronic atrial fibrillation after ineffective DC cardioversion were included in the study. Repeat DC cardioversion was performed after loading with oral amiodarone, 10–15 mg/kg body weight/day for a period necessary to achieve the cumulative dose of over 6.0 g.
Results: Spontaneous conversion to sinus rhythm during amiodarone pretreatment was achieved in 9 of 49 patients (18%). Direct‐current cardioversion was performed in 39 patients and sinus rhythm was achieved in 23 of these patients (59%). Mean heart rate decreased from 95 beats/min before to 68 beats/min after DC cardioversion (p<0.001). Systolic blood pressure significantly (p<0.05) decreased from 126 ± 23 to 108 ± 25 mmHg. Complications occurring in four patients just after electroconversion were well tolerated and of short duration. After 12 months, 52% of patients maintained sinus rhythm on low dose (200 mg/day) amiodarone therapy.
Conclusion: Pretreatment with amiodarone and repeat DC cardioversion allows for restoration of sinus rhythm in about 65% of patients with chronic atrial fibrillation after first ineffective DC cardioversion. Direct‐current cardioversion can be performed safely with the use of standard precautions in patients who are receiving amiodarone. At 12 months' follow‐up, more than 50% of patients maintain sinus rhythm on low‐dose amiodarone after successful repeat cardioversion.
Keywords: amiodarone, chronic atrial fibrillation, repeat cardioversion
Full Text
The Full Text of this article is available as a PDF (377.5 KB).
References
- 1. Lown B: Electrical reversion of cardiac arrhythmias. Br Heart J 1976; 29: 469–489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Mancini J, Goldberg AI: Cardioversion of atrial fibrillation: Consideration of embolization, anticoagulation, prophylactic pacemaker and long term success. Am Heart J 1982; 104: 617–621. [DOI] [PubMed] [Google Scholar]
- 3. Ewy GA, Ulfers L, Hager HD, Rosenfeld AR, Roeske WR, Goldman S: Response of atrial fibrillation to therapy: Role of etiology and left atrial diameter. Electrocardiology 1980; 13: 119–124. [DOI] [PubMed] [Google Scholar]
- 4. Lundstrom T, Ryden L: Chronic atrial fibrillation: Long term results of direct current conversion. Acta Med Stand 1988; 223: 53–59. [PubMed] [Google Scholar]
- 5. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC: Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta‐analysis of randomized control trials. Circulation 1990; 82: 1106–1116. [DOI] [PubMed] [Google Scholar]
- 6. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin J: Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992; 20: 527–532. [DOI] [PubMed] [Google Scholar]
- 7. Brodsky MA, Allen BJ, Walker CJ, Casey TP, Luchet CR, Henry WL: Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium. Am J Cardiol 1987; 60: 572–575. [DOI] [PubMed] [Google Scholar]
- 8. Gold RL, Haffajee CI, Charos K, Sloan K, Baker K, Baker S, Alpert JS: Amiodarone for refractory atrial fibrillation. Am J Cardiol 1986; 57: 124–127. [DOI] [PubMed] [Google Scholar]
- 9. Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, Brady PM, Kay HR: Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. J Am Coll Cardiol 1985; 6: 1402–1406. [DOI] [PubMed] [Google Scholar]
- 10. Crijns HJ, Van Gelder IC, Van Gilst WH, Hillege H, Gosselink AM, Lie KJ: Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol 1991; 68: 335–341. [DOI] [PubMed] [Google Scholar]
- 11. Grayboys TB, Podrid PJ, Lown B: Efficacy of amiodarone for refractory supraventricular tachyarrhythmias. Am Heart J 1983; 106: 870–876. [DOI] [PubMed] [Google Scholar]
- 12. Gosselink ATM, Crijns HJGM, Van Gelder IC, Hillige H, Wiesfeld ACP, Lie KI: Low‐dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. J Am Med Assoc 1992; 267: 3289–3293. [PubMed] [Google Scholar]
- 13. Middlekauff HR, Wiener J, Stevenson WG: Low‐dose amiodarone for atrial fibrillation. Am J Cardiol 1993; 72: 75F–81F. [DOI] [PubMed] [Google Scholar]
- 14. Sagrista‐Sauleda J, Permanyer‐Miralda G, Soler‐Soler J: Electrical cardioversion after amiodarone administration. Am Heart J 1992; 123: 1536–1542. [DOI] [PubMed] [Google Scholar]
- 15. Gosselink ATM, Crijns HJGM, Hillege H, Lie KI: Factors determining conversion of difficult‐to‐treat atrial fibrillation and flutter on oral amiodarone (abstr). J Am Coll Cardiol 1993; 21: 202A. [Google Scholar]
- 16. Chun SA, Sager PT, Stevenson WG, Nademanee K, Middlekauff R, Singh BN: Long‐term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 1995; 76: 47–50. [DOI] [PubMed] [Google Scholar]